Database: European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (European Union)

From Beacon
Revision as of 19:43, 27 June 2024 by Francine (talk | contribs)

Go back to European Union page

Type of Database: pharmacovigilance; registry; survey; clinical trial database; research study; administrative/claims data.

Primary purpose: To serve as a centralized electronic index for EU research organizations, networks, and data sources in the fields of pharmacoepidemiology and pharmacovigilance. It aims to facilitate connections between researchers and study sponsors by providing information on expertise and research experience across Europe. The databases allows users to identify relevant research centers, data sources, and patient registries based on various criteria.

Sponsor, manager or home institution: European Medicines Agency (EMA).

Type of information: cross-sectional; longitudinal. diagnosis; medication use; causes of death; medical procedures; devices; sex; age; region; healthcare costs; type of patient.

Data Dictionary: European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.

Click here to learn more

Source of Information: The sources of the databases are provided and maintained by the listed organizations, data providers, or registry holders.

Data level: national level and regional level.

Number of Records: unknown.

Date range: unknown.

Cancer Areas of Interest: C00-D48: All neoplasms. Click here to learn more.

Data access: publicly available. Click here to access. Data can be downloaded in the PDF format.

Contact information: Click here to learn more.